¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"toxic shock syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® congenital rubella syndrome ÇÑ±Û ¼±ÃµÇ³ÁøÁõÈıº
¼³¸í   
  ÀӽűⰣ Áß¿¡ »ê¸ð°¡ Ç³Áø¿¡ °É¸®¸é À̠dzÁø ¹ÙÀÌ·¯½º´Â Å¹ÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô Àü´ÞµÇ¾î¼­ Å¾ÆÀǠdzÁø°¨¿°À» ÀÏÀ¸Å²´Ù. ÀӽŠù 3°³¿ù µ¿¾È, Æ¯È÷ ÀӽŠù´Þ¿¡ Å¾ư¡ Ç³ÁøÀÇ °¨¿°À» ¹ÞÀ¸¸é, ½Å»ý¾Æ¿¡¼­ ¼±Ãµ±âÇü, Áï ´«¿¡¼­ ÃÐÁ¡À» Á¤È®È÷ ¸ÂÃß¾îÁִ ·»ÁîÀÇ ¿ªÇÒÀ» Çϴ ¼öÁ¤Ã¼ÀǠȥŹ(¹é³»Àå), ½ÉÀå±âÇü, ±Í¸Ó°Å¸® ¹× ½ÉÇÑ Áö´É¹Ú¾àÀ» µ¿¹ÝÇϴ ¼ÒµÎÁõ µîÀÌ ¹ß»ýÇϴ ¼ö°¡ ¸¹´Ù.
¿µ¹® carpal tunnel syndrome ÇÑ±Û ¼Õ¸ñ±¼ÁõÈıº
¼³¸í   
  ¼Õ¸ñ¿¡´Â ¾ÆÈ© °³ÀÇ ÈûÁÙ°ú ÇÑ °³ÀÇ ½Å°æÀÌ Åë°úÇϴ ±¼ÀÌ Àִµ¥ À̰÷À» ¼Õ¸ñ±¼À̶ó Çϰí, À̰÷À» Áö³ª´Â ½Å°æÀÌ ´­¸®¸é »õ±ú¼Õ°¡¶ôÀ» Á¦¿ÜÇÑ ³× ¼Õ°¡¶ôÀÌ ¾ÆÇÁ°í Àú¸° Áõ»óÀÌ´Ù. À̰ÍÀ» ¼Õ¸ñ±¼ÁõÈıºÀ̶ó ÇÑ´Ù. °Ë»ç ¹æ¹ýÀ¸·Î´Â ±ÙÀ° °Ë»ç¿Í ½Å°æÀü´Þ°Ë»ç°¡ ÀÖ´Ù. ½ÉÇÒ ¶§´Â ¾ÆÄ§À̳ª Àú³á¿¡ ¾ÆÆÄ¼­ ÀáÀ» ±ú°í ¼Õ¸ñ»Ó¸¸ ¾Æ´Ï¶ó ¾î±ú±îÁö ¾ÆÇÁ´Ù. ¼Õ¸ñÀ» ±ÁÈ÷°í ÀÖÀ¸¸é ÅëÁõÀÌ ½ÉÇÏ´Ù. ¼Õ¸ñÀ» ¹Ýº¹ÀûÀ¸·Î »ç¿ëÇϴ ¿îÀüÀÚ, °¡Á¤ÁÖºÎ, ¾Ç±â ¿¬ÁÖÀÚ, °øÀå¶óÀÎÀÇ ±Ù·ÎÀÚ, ÄÄÇ»ÅÍ »ç¿ëÀÚ, ¸ñ¼ö°¡ ÇØ´çµÈ´Ù. ¼Õ¹Ù´Ú»À°¡ ±úÁö°Å³ª ³Ñ¾îÁö¸é¼­ ¼Õ¹Ù´ÚÀ¸·Î Â¤¾úÀ» ¶§µµ ¹ß»ýÇϸ砵幰°Ô Áøµ¿Çϴ °ø±¸¸¦ »ç¿ëÇØµµ ³ªÅ¸³ª±âµµ ÇÑ´Ù. ÀÓ»êºÎ, Åëdz, ·ù¸¶Æ¼½º °üÀý¿°, °©»ó»ù ±â´É ÀúÇÏÁõ, ´ç´¢º´ µîÀÌ ÀÖÀ» ¶§ ÀÌ·± Áõ»óÀÌ ¿Ã ¼ö ÀÖ´Ù. ¿©ÀÚ¿¡°Ô ´õ ¸¹°í ÁַΠÀÚÁÖ ¾²´Â ¼Õ¸ñÀÌ ÇØ´çµÈ´Ù. ½ÉÇÒ ¶§´Â ¼Õ¸ñ¿¡ ¶¥ÄḸÇÑ Å©±â·Î ºÎ¾î¿À¸¥´Ù. ´©¸£¸é ¾ÈÀ¸·Î ¾¦ µé¾î°¡±âµµ ÇÏ°í ´Ù½Ã ¿òÁ÷ÀÌ¸é Æ¢¾î³ª¿Â´Ù. ¼Õ¸ñ»À ¿©´ü °³ Áß¿¡ ¹Ý´Þ»À¶ó ºÒ¸®´Â ÀÛÀº»ÀÀÇ Àδ밡 À̿ϵǾý±ä´Ù. ÅëÁõÀ» °¨¼ÒÇϴ ġ·á·Î ºÎ¸ñ, ¾óÀ½ÂòÁú, ÀÌ´¢Á¦, Ç×»ýÁ¦¸¦ »ç¿ëÇϱ⵵ Çϸç ÅëÁõÀÌ °è¼ÓµÇ¸é ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å È£¸£¸óÀ» ¼Õ¸ñºÎ¿¡ ÁÖ»çÇÏ¿© ÅëÁõÀ» ÁÙÀδÙ. ºÎÀÛ¿ëÀ¸·Î´Â Àç¹ß·üÀÌ ³ô´Ù. 
¿µ¹® sudden infant death syndrome ÇÑ±Û ¿µ¾Æ±Þ»çÁõÈıº
¼³¸í   
  ÇÑ »ì ÀÌÇÏÀÇ °Ç°­ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀΠ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼­ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°­°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼­ Å¾ ¿µ¾Æ¿¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀΠ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
¿µ¹® severe acute respiratory syndrome(SARS) ÇÑ±Û ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº
¼³¸í   
  Áß±¹ ±¤µ¿ Áö¿ª¿¡¼­ °¡Àå ¸ÕÀú ¹ß»ýÇÑ Àü¿°¼ºÈ£Èí±âº´À¸·Î ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­ ¡®ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº(SARS)'À¸·Î ¸í¸íÇß´Ù. ¼·¾¾ 38µµ ÀÌ»óÀÇ °í¿­°ú ±âħ, È£Èí°ï¶õ, Àú»ê¼ÒÁõ, X¼±»óÀÇ Æó·ÅÁõ»ó Áß Çϳª ÀÌ»óÀÇ Áõ»óÀÌ ³ªÅ¸³ª¸ç, µÎÅë, ±ÙÀ°Åë, ½Ä¿åºÎÁø, ÇǷΰ¨, ¹ßÁø, ¼³»ç¸¦ µ¿¹ÝÇÒ ¼ö ÀÖ´Ù. Ãʱâ Áõ»óÀº °¨±â¿Í ºñ½ÁÇÏÁö¸¸ Æó·ÅÀ¸·Î ¹ßÀüÇϸé Ä¡¸íÀûÀÏ ¼ö ÀÖ´Ù. ÇöÀç ¹àÇôÁø °¨¿°°æ·Î´Â È¯ÀÚ°¡ Àçä±â³ª ±âħÇÒ ¶§ ³»»Õ´Â Ä§¹æ¿ïÀ̰í, À̰ÍÀÌ ´Ù¸¥ »ç¶÷ÀǠȣÈí±â·Î µé¾î°¥ ¶§ Àü¿°µÈ´Ù. Ä§¹æ¿ïÀÌ Àü´ÞµÇ´Â °Å¸®´Â º¸Åë 1m·Î º¸°í ÀÖ´Ù. °ø±â¸¦ ÅëÇØ Àü¿°ÀÌ °¡´ÉÇϴٴ ÁÖÀåÀÌ Á¦±âµÆÁö¸¸ ¾ÆÁ÷ È®ÀεÇÁö ¾Ê¾Ò´Ù. ¿øÀαÕÀº º¯Á¾ Äڷγª¹ÙÀÌ·¯½º·Î ¹àÇôÁ³´Ù.
¿µ¹® syndrome ÇÑ±Û ÁõÈıº
¼³¸í   
  Áõ»óÀÇ ÁýÇÕ. ¾î¶² Áúº´ÀǠ¡ÈÄÀÇ ÃÑÇÕÀ» ¸»ÇÑ´Ù. ´ë°³ ±× ¿øÀÎÀº ¾Ë ¼ö ¾øÀ¸³ª, Áõ»óÀÌ º¹ÇÕÀûÀ¸·Î ³ªÅ¸³ª°í ÀÌ¿¡ ´ëÇÑ Ä¡·á°¡ ÀÏÁ¤ÇÑ °æ¿ì ÇϳªÀÇ ÁõÈıºÀ¸·Î Ãë±ÞÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • surgical shock
    ¼ö¼ú¼îÅ©
  • secondary shock
    ÀÌÂ÷¼îÅ©, ¼Ó¹ß¼îÅ©
  • septic shock
    ÆÐÇ÷¼îÅ©
  • serum shock
    Ç÷û¼îÅ©
  • shell shock
    Æ÷ź¼îÅ©, Æ÷ÅºÃæ°Ý
  • shock
    1. ¼îÅ© 2. Ãæ°Ý
  • shock absorber
    Ãæ°ÝÈí¼öÁ¦, ¿ÏÃæ±â
  • shock lung
    ¼îÅ©Æó, ¼îÅ©ÇãÆÄ
  • shock treatment
    Ãæ°ÝÄ¡·á
  • shock wave lithotripsy
    Ãæ°ÝÆÄ¼â¼®(¼ú)
  • vagogenic shock
    ¹ÌÁֽŰæ¼îÅ©
  • anginal syndrome
    Çù½ÉÁõÁõÈıº
  • anterior interosseous nerve syndrome
    ¾Õ»À»çÀ̽ŰæÁõÈıº, Àü¹æ°ñ°£½Å°æÁõÈıº
  • anterior spinal artery syndrome
    ¾Õô¼öµ¿¸ÆÁõÈıº
  • anterior tibial compartment syndrome
    Á¾¾Æ¸®¾ÕÄ­ÁõÈıº, ¾ÕÁ¤°­±¸È¹ÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Guillain-Barre syndrome
    (¢¡acute idiopathic polyneuritis) ±Þ¼ºÆ¯¹ß´Ù¹ß½Å°æ¿° , ±Þ¼ºÆ¯¹ß¿©·¯½Å°æ¿°
  • hemolytic uremic syndrome
    ¿ëÇ÷¿äµ¶ÁõÈıº
  • hemorrhagic fever with renal syndrome
    ÃâÇ÷¿­ÄáÆÏÁõÈıº
  • hepatorenal syndrome
    °£ÄáÆÏÁõÈıº
  • irritable bowel syndrome
    °ú¹Î´ëÀåÁõÈıº
  • Kallmann syndrome
    Ä®¸¸ÁõÈıº
  • Klinefelter's syndrome
    Ŭ¶óÀÎÆçÅÍÁõÈıº
  • Korsakoff's syndrome
    ÄÚ¸£»çÄÚÇÁÁõÈıº
  • locked-in syndrome
    °¨±ÝÁõÈıº
  • Mallory-Weiss syndrome
    ¸»·Î¸®¹ÙÀ̽ºÁõÈıº
  • Marfan syndrome
    ¸¶¸£ÆÇÁõÈıº
  • myelodysplastic syndrome
    °ñ¼öÇü¼ºÀÌ»óÁõÈıº
  • nephritic syndrome
    ÄáÆÏ¿°ÁõÈıº
  • nephrotic syndrome
    ÄáÆÏÁõÈıº, ½ÅÁõÈıº
  • neuroleptic malignant syndrome
    Ç×Á¤½Åº´¾à¹°¾Ç¼ºÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • naturally toxic plant
    ÀÚ¿¬µ¶¼º½Ä¹°
  • toxic nephropathy
    µ¶¼ÒÄáÆÏº´Áõ
  • toxic nephrosis
    µ¶¼ºÄáÆÏÁõ
  • toxic neuritis
    µ¶¼º½Å°æ¿°
  • toxic epidermal necrolysis
    µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ
  • toxic peripheral neuropathy
    µ¶¼º¸»ÃʽŰ溴Áõ
  • toxic psychosis
    µ¶¼ºÁ¤½Åº´
  • toxic reaction
    µ¶¹ÝÀÀ, Áßµ¶¹ÝÀÀ
  • toxic retinopathy
    Áßµ¶¸Á¸·º´Áõ
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • toxic stomatitis
    µ¶¼ºÀԾȿ°, µ¶¼º±¸³»¿°
  • toxic substance
    µ¶¼º¹°Áú
  • toxic
    µ¶¼º-, Áßµ¶-
  • toxic tolerance
    µ¶¹°³»¼º
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©, Ãʰú¹Î¹ÝÀÀ¼îÅ©
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Cowdens syndrome = multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
  • ICE syndrome=iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • Lowes syndrome->oculocerebrorenal syndrome
    ·Î¿ìÁõÈıº
  • PIE syndrome => pulmonary infiltration with eosinophilia syndrome
    È£»ê±¸Áõ°¡¼º ÆóħÀ± ÁõÈıº
  • Q-T prolongation syndrome ; long Q-T syndrome
    Q-T°£°Ý ¿¬ÀåÁõÈıº.
  • Raeders syndrome=>painful Horners syndrome
    ·¹ÀÌ´õÁõÈıº
  • Steiners syndrome [=curtius syndrome, facial hemi
    ¾È¸é¹Ý(ÂÊ)ºñ´ëÁõ
  • UGH syndrome->uveitis-glaucoma-hemorrhage syndrome
    À¯Áö¿¡ÀÌÃëÁõÈıº
  • A-V syndrome
    A-VÁõÈıº
  • Acquiered immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌÁõÈıº
  • Adams Stokes syndrome
    ¾Ö´ý½º-½ºÅäÅ©½ºÁõÈıº.
  • Albrights syndrome
    ¾Ëºê¶óÀÌÆ® ÁõÈıº(~ ñøý¦ÏØ)
  • Alezzandrinis syndrome
    ¾Ë·¹Àܵ帮´ÏÁõÈıº
  • Alports syndrome
    ¾ËÆ÷Æ® ÁõÈıº
  • Alstr ms syndrome
    ¾Ë½ºÆ®·Ý ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • toxic atrophy
    Áßµ¶¼ºÀ§Ãà(ñéÔ¸àõê×õê)
  • toxic cardiopathy
    Áßµ¶¼º½ÉÀ庴Áõ
  • toxic cataract
    Áßµ¶¹é³»Àå(¡­ÛÜÒ®î¡).
  • toxic cataract
    Áßµ¶¼º¹é³»Àå(¡­ÛÜÒ®î¡)
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • toxic chemical use
    µ¶¼ºÈ­Çй°ÁúÀÌ¿ë
  • toxic conjunctivitis
    Áßµ¶°á¸·¿°
  • toxic convulsion
    Áßµ¶¼º°æ·Ã(¡­ÌâÕý)
  • toxic convulsion
    Áßµ¶¼º°æ·Ã(¡­ÌâÕý).
  • toxic deafness
    Áßµ¶¼º³­Ã»
  • toxic delirium
    µ¶¼º¼¶¸Á(~àëØÍ).
  • toxic dementia
    Áßµ¶¼ºÄ¡¸Å(¡­öÂ?)
  • toxic diarrhea
    Áßµ¶¼º¼³»ç
  • toxic dose
    Áßµ¶(¿ë)·®(ñéÔ¸(éÄ)åÖ).
  • toxic dose
    µ¶¼º¿ë·®
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Meniere's syndrome
    ¸Þ´Ï¿¡¸£ÁõÈıº
  • middle lobe syndrome
    Áß¿±ÁõÈıº
  • mucocutaneous lymph node syndrome
    ÇǺÎÁ¡¸·¸²ÇÁÀýÁõÈıº
  • mucocutaneous ocular syndrome
    ÇǺÎÁ¡¸·¾ÈÁõÈıº
  • nephrotic syndrome
    ½ÅÁõÈıº, ³×ÇÁ·Î½Ã½ºÁõÈıº
  • omental adhesion syndrome
    ´ë¸Á¸·À¯ÂøÁõÈıº
  • overlap syndrome
    ÁßøÁõÈıº
  • Pancoast syndrome
    ÆÇÄÚ½ºÆ® ½Åµå·Ò
  • parietooccipital syndrome
    µÎÁ¤¿±Èĵο±ÁõÈıº
  • peutz-Jegher's syndrome
    Æ÷ÀÌÃ÷-¿¹°ÅÁõÈıº
  • PIE syndrome
    È£»ê±¸¼ºÆóħ½ÀÁõÈıº
  • Poland syndrome
    Æú¶õµåÁõÈıº
  • posterior interosseous syndrome
    Èİñ°£ÁõÈıº
  • postgastrectomy syndrome
    À§ÀýÁ¦ÈÄÁõÈıº
  • postmenopausal syndrome
    Æó°æÈÄÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TSA technical surgical assistance; toluene sulfonic acid; total shoulder arthroplasty; total solute abso...
TSAP toxic-shock-associated protein
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
PCS palliative care service; Patient Care System; patterns of care study; pelvic congestion syndrome; ph...
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ATSDR Agency for Toxic Substances and Disease Registry
TEN Toxic epidermal necrolisis
TEF Toxic Equivalency Factor
TEQ Toxic Equivalents
TRI Toxic Release Inventory
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • shock lung
    ¼îÅ© Æó
    ÃâÇ÷¼º ¼îÅ© µî¿¡ ÇÕº´Çϴ ȣÈí ºÎÀü.
  • shock position
    ¼ï À§Ä¡
    ȯÀÚ°¡ ¼îÅ©¸¦ ÀÏÀ¸Ä×À» ¶§ ±× ±¸±Þ üÀ§·Î¼­ ÃëÇØÁö´Â üÀ§.
  • shock shortening heat
    ´ÜÃà ¿­
    ´ÜÃàÇÏ´Â ±æÀÌ¿¡ ºñ·ÊÇØ ºÎÇÏ¿¡ °ü°è¾øÀÌ ¹ß»ýÇÏ´Â ¿­.
  • shock term memory
    ´Ü±â ±â¾ï
  • shock treatment
    ¼ï Ä¡·á
    Ä«¸£µð¾ÆÁ¹ °æ·Ã ¿ä¹ý, Àü±â ¼îÅ© ¿ä¹ý, Àν¶¸° ¼îÅ© ¿ä¹ý µîÀÌ ÀÖ´Ù.
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • state of shock
    Ãæ°Ý »óÅÂ
  • wound shock
    ¿Ü»ó¼º ¼ï
  • A-V syndrome
    A-V ÁõÈıº
  • Aarskog syndrome
    ¾Æ¸£½ºÄÚ±× ÁõÈıº
    À¯Àü¼º ÁõÈıºÀÇ Çϳª·Î X-¿¬°ü¼º ÇüÁú·Î À¯ÀüµÈ´Ù. Ư¡À¸·Î´Â ¾È±¸ °Ý¸®Áõ, ³ÐÀº À­ ÀÔ¼ú, ¼î¿Ã, ÀÛÀº ¼Õ µîÀÌ ÀÖ´Ù. ¾È¸é ¼º±â Çü¼º Àå¾Ö
  • Aase syndrome
    ¾ÆÁî ÁõÈıº
    °æ¹ÌÇÑ ¼ºÀå Áö¿¬, ÀúÇü¼º ºóÇ÷, ´Ù¾çÇÑ ¹éÇ÷±¸ °¨¼ÒÁõ, ¼¼ °³·Î °¥¶óÁø ¾öÁö¹ß°¡¶ô, Á¼Àº ¾î±ú, ´ÊÀº õ¹® Æó¼â, ¾ðûÀÌ, ±¸°³ ÆÄ¿­, ¸Á¸·º´Áõ µîÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ¸·Î¼­ ¿­¼ºÀ¸·Î À¯ÀüµÇ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • abnormal laterality syndrome
    ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıº
    ½ÉÀå¿¡¼­ Á¤»óÀûÀÎ ÁÂ¿ì ´ëĪÀÌ µÚ¹Ù²î°Å³ª ºÒ¿ÏÀüÇÑ °æ¿ì·Î¼­, ÁÂÃøÀ̳ª ¿ìÃøÇüÀ¸·Î ´ëĪÀÎ °æ¿ì°¡ ÀÖ°í À̵鿡¼­ ¿©·¯ °¡Áö ½ÉÀå ±âÇüÀÌ µ¿¹ÝµÇ´Âµ¥ ÀÌ·¯ÇÑ °æ¿ì¸¦ ½ÉÀåÀÇ ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıºÀ̶ó ÇÑ´Ù. À̵é Áúȯ¿¡¼­´Â ½ÉÀå »Ó ¾Æ´Ï¶ó ÁÖ ±â°üÁö¿Í »óÆóµ¿¸ÆÀÇ À§Ä¡ °ü°è ¹× ÆóÀÇ ºÐ¿±, °£°ú ºñÀåÀÇ ÇüÅ ¹× À§Ä¡°¡ ´Þ¶óÁö¸ç ƯÈ÷ ºñÀåÀÌ ¾ø´Â ¹«ºñÁõ
  • absent pulmonary valve syndrome
    Æó µ¿¸Æ ÆÇ °á¿© ÁõÈıº
    ´Üµ¶À¸·Î ÀϾ´Â °æ¿ì´Â ±ØÈ÷ µå¹°¸ç, ½É½Ç Áß°Ý °á¼Õ, ¿ì½Ç ´©µÎºÎ ÇùÂø¿¡ ÇÕº´ÇÏ´Â °æ¿ì°¡ ºñ±³Àû ¸¹´Ù. Áï Fallot 4ÁõÈÄÀÇ ÇÕº´ ±âÇüÀ¸·Î ³ªÅ¸³­´Ù. ÀÌ °æ¿ì ÁÂ¿ì Æóµ¿¸ÆÀÇ È®´ë, ¥±À½ Æóµ¿¸Æ ¼ººÐÀÇ ¿ÏÀü ¼Ò½Ç, ÇÇÄ¡°¡ ³·Àº È®Àå±â ÀâÀ½À» ³ªÅ¸³½´Ù. À̰ÍÀ» µ¿¹ÝÇÑ Fallot 4ÁõÈÄ´Â À¯¾Æ±â¿¡ ¿ïÇ÷¼º ½ÉºÎÀüÀ» ÀÏÀ¸Å°±â ½±´Ù.
  • absent testes syndrome
    °íȯ °á¿© ÁõÈıº
  • abstinence syndrome
    ±Ý´Ü ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
toxic retinopathy Retinal changes due to prolonged administration of various drugs.
(05 Mar 2000)
toxic substances A chemical or mixture of chemicals that presents a high risk of injury to human health or to the environment.
(05 Dec 1998)
toxic tetanus Tonic spasms caused by strychnine or other tetanic.
Synonym: toxic tetanus.
(05 Mar 2000)
toxic unit A unit formerly synonymous with minimal lethal dose but which, because of the instability of toxins, is now measured in terms of the quantity of standard antitoxin with which the toxin combines.
See: L doses, minimal lethal dose.
Synonym: toxin unit.
(05 Mar 2000)
epidermal necrolysis, toxic An exfoliative disease of skin seen primarily in adults and characterised by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded. It results primarily from a toxic reaction to various drugs, but occasionally occurs as a result of infection, neoplastic conditions, or other exposure.
(12 Dec 1998)
anaesthetic shock Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage.
(05 Mar 2000)
anaphylactic shock <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
anaphylactoid shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
break shock The shock produced by breaking a constant current passing through the body.
(05 Mar 2000)
cardiac shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiogenic shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiopulmonary obstructive shock <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues).
Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis.
(27 Sep 1997)
vasogenic shock Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate.
(05 Mar 2000)
reversible shock Shock that will respond to treatment and from which recovery is possible.
(05 Mar 2000)
chronic shock The state of peripheral circulatory insufficiency developing in elderly patients with a debilitating disease, e.g., carcinoma; a subnormal blood volume makes the patient susceptible to haemorrhagic shock as a result of even a moderate blood loss such as may occur during an operation.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • shock therapy
    (Á¤½Åº´ÀÇ)Ãæ°Ý(Àü°Ý)¿ä¹ý
  • shock troops
    Ư°ø´ë
  • shock wave
    Ãæ°ÝÆÄ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á